Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-analysis.

MLA

Kang, HeeEun, et al. “Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-Analysis.” Open Forum Infectious Diseases, vol. 10, no. 10, Oct. 2023, pp. 1–7. EBSCOhost, https://doi.org/10.1093/ofid/ofad472.

APA

Kang, H., Uy, J. P., Ho, C. C., Blunt, H. B., Riblet, N. B., Pasqualotto, A. C., & Murphy, R. A. (2023). Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-analysis. Open Forum Infectious Diseases, 10(10), 1–7. https://doi.org/10.1093/ofid/ofad472

Chicago

Kang, HeeEun, John P Uy, Caroline C Ho, Heather B Blunt, Natalie B Riblet, Alessandro C Pasqualotto, and Richard A Murphy. 2023. “Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-Analysis.” Open Forum Infectious Diseases 10 (10): 1–7. doi:10.1093/ofid/ofad472.